Word: crixivan
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...particular drug company has been a significant player in Botswana: Merck. The U.S. firm created some of the first ARVs capable of treating HIV and AIDS (Crixivan and Stocrin), but has in the past been criticized for its methods of distributing them. In 2004, MSF singled out Merck for reneging on commitments to release the medicines at a cost of less than $1 per person per day. Merck was hurt by such accusations. (According to the firm's website, its founder, George W. Merck, once said: "We try never to forget that medicine is for the people...
...public relations woes, Bristol-Meyers-Squibb Pharmaceuticals announced last week that it would market its AIDS drugs, Zerit and Videx, to Africa at a combined price of $1 per day. This follows closely on the heels of Merck Pharmaceuticals' announcement that it would market its drug, the protease inhibitor Crixivan, to Africa at the reduced price of $600 per year. AIDS drugs typically cost between $10,000 and $15,000 per year. Needless to say, because of these exorbitantly high prices, these drugs are out of reach for those most in need--especially those in sub-Saharan Africa, quickly becoming...
...deadly stalemate seems to be breaking up. Last week, even as the big pharmaceutical companies went to court to keep generic copies of their drugs out of South Africa, one of the biggest of these, Merck, announced it would slash prices of two of its major AIDS drugs, Crixivan and Stocrin, an additional 40% to 55%. Other drug giants--including GlaxoSmithKline and Bristol-Myers Squibb--immediately signaled they would follow suit...